- Global Pharma News & Resources

Global Cancer Supportive Care Drug Market Size & Share Surge to USD 22,760.32 Million by 2026

According to Facts and Factors, the global Cancer Supportive Care Drug market in 2019 is approximately USD 21,230.12 Million. The market is anticipated to grow at a CAGR of 1.1% and is projected to reach around USD 22,760.32 Million by 2026.

Cancer is a group of diseases, describe as an abnormal cell growth which may not or may move to the other part of the body. In order to control cancer, many drug therapies are prescribed by a physician. The supportive drug is the medicine that is not the active part of therapy but incorporated in the remedy for the better management of disorders. The various drug is used as supportive drugs are G-CSFs, Bisphosphonates, Antiemetics, Opioids, NSAIDs, ESAs, and Others.

The cancer supportive care drug market is highly driven by increasing number of cancer-related disorders across the world. In addition, increasing aging population in Europe and North America is also one of the major factors driving the growth of the market. Furthermore, an increasing portion of the population with high per capita healthcare expenditures coupled with early detection is one of the major driving factors for this market. Various factors such as increasing the use of immune-oncology agents and other alternatives may restraint the growth of the market. Increasing research and development and pipeline drugs may be considered as futuristic opportunities within the forecast periods.

Request an Exclusive Free Sample PDF Report of Cancer Supportive Care Drug Market:

(The sample of this report is readily available on request).

Benefits of Requesting a “FREE PDF” Sample Report Before Purchase:

  • Novel COVID-19 potential impact & current market situation analysis
  • A brief introduction to the research report and an overview of the market
  • Graphical introduction of global as well as regional analysis.
  • Know top players in the market with their revenue analysis.
  • Selected illustrations of market insights and trends.
  • Example pages from the report.
  • FnF research methodology.

(Note: The sample of this report is updated with COVID-19 impact analysis before delivery)

Spreadsheet Chapters include

Market Consumption – in US$ by Country by Product/Service by Year. Market, Financial, Competitive, Market Segmentation, Industry, Critical Parameters, Marketing Costs, Markets, Decision Makers, Performance, Product Launch.

In product type, the market is classified into seven types G-CSFs, Opioids, Antiemetics, Bisphosphonates, ESAs, NSAIDs, and Others. At present, G-CSFs used for neutropenia (CIN), For Anemia ESAs (CIA), for nausea and vomiting; antiemetics (CINV), bisphosphonates for cancer-induced bone diseases, and NSAIDs and opioids for the treatment of cancer pain. In terms of therapeutic Class, granulocytes stimulating factors accounted for the largest market shares in the year 2019 and the same remains continuous within the forecasted year followed by opioids.

Enquire more about this report before purchase @

(You may enquire a report quote OR available discount offers to our sales team before purchase.)

Based on end-users, the market is classified into Specialty clinics, hospitals, direct to consumers, and others. Public and Private Hospitals combined accounts for the largest market shares in the year 2019. This segment accounts for around more than 70% of market shares in the year 2019.

North America accounts for the largest market share in the year 2019. As per our analysis, North America accounted for more than 40% of the market share in the year 2019. Fast treatment, Public awareness, High literacy rate, advanced healthcare infrastructures are some of the major factors driving for this region. European Market is mainly driven by countries like the UK, Germany, France, Italy, and Spain. High per capita income is one of the major driving factors for this country. Brazil is the major driving country for the Latin America Market. Brazil contributes more than half of the revenue shares in the Latin American Region.

Some of the major players operating in Amgen, Merck, Novartis, Johnson & Johnson, Roche, Helsinn Healthcare, Heron Pharma, Tesaro, and Purdue Pharma amongst others.

Request Customized Copy of Report @

(We customize your report according to your research need. Ask our sales team for report customization.)

This report segments the Cancer Supportive Care Drug market as follows:

Global Cancer Supportive Care Drug MarketType Segment Analysis

  • G-CSFs
  • Bisphosphonates
  • Antiemetics
  • Opioids
  • NSAIDs
  • ESAs
  • Others

Global Cancer Supportive Care Drug MarketDistribution Channel Segment Analysis

  • Hospital
  • Pharmacy
  • Others

Global Cancer Supportive Care Drug MarketRegional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest Of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • The Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

About Us:

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 06-Aug-2020